• British Pharmacopoeia Volume I & II
  • Monographs: Medicinal and Pharmaceutical Substances

Paracetamol

European Union chaplet of stars
scroll to previous hit
scroll to next hit
General Notices

(Ph. Eur. monograph 0049)

bp2013_v2_13_medicinal_and_pharmaceutical_substances_14 paracetamol_1_2012_70_cs.png


C8H9NO2    151.2    103-90-2

Action and use

Analgesic; antipyretic.

Preparations

Co-codamol Tablets

Co-codamol Capsules

Effervescent Co-codamol Tablets

Co-dydramol Tablets

Co-proxamol Tablets

Paracetamol Capsules

Paediatric Paracetamol Oral Solution

Paediatric Paracetamol Oral Suspension

Paracetamol Oral Suspension

Paracetamol Suppositories

Paracetamol Tablets

Paracetamol and Caffeine Tablets

Soluble Paracetamol and Caffeine Tablets

Dispersible Paracetamol Tablets

Soluble Paracetamol Tablets

Paracetamol, Codeine Phosphate and Caffeine Capsules

Paracetamol, Codeine Phosphate and Caffeine Tablets

Ph Eur

DEFINITION

N-(4-Hydroxyphenyl)acetamide.

Content

99.0 per cent to 101.0 per cent (dried substance).

CHARACTERS
Appearance

White or almost white, crystalline powder.

Solubility

Sparingly soluble in water, freely soluble in alcohol, very slightly soluble in methylene chloride.

IDENTIFICATION

First identification   A, C.

Second identification   A, B, D, E.

A. Melting point (2.2.14): 168 °C to 172 °C.

B. Dissolve 0.1 g in methanol R and dilute to 100.0 mL with the same solvent. To 1.0 mL of the solution add 0.5 mL of a 10.3 g/L solution of hydrochloric acid R and dilute to 100.0 mL with methanol R. Protect the solution from bright light and immediately measure the absorbance (2.2.25) at the absorption maximum at 249 nm. The specific absorbance at the maximum is 860 to 980.

C. Infrared absorption spectrophotometry (2.2.24).

Preparation  Discs.

Comparison   paracetamol CRS.

D. To 0.1 g add 1 mL of hydrochloric acid R, heat to boiling for 3 min, add 1 mL of water R and cool in an ice bath. No precipitate is formed. Add 0.05 mL of a 4.9 g/L solution of potassium dichromate R. A violet colour develops which does not change to red.

E. It gives the reaction of acetyl (2.3.1). Heat over a naked flame.

TESTS
Related substances

Liquid chromatography (2.2.29). Prepare the solutions immediately before use.

Test solution  Dissolve 0.200 g of the substance to be examined in 2.5 mL of methanol R containing 4.6 g/L of a 400 g/L solution of tetrabutylammonium hydroxide R and dilute to 10.0 mL with a mixture of equal volumes of a 17.9 g/L solution of disodium hydrogen phosphate R and of a 7.8 g/L solution of sodium dihydrogen phosphate R.

Reference solution (a)  Dilute 1.0 mL of the test solution to 50.0 mL with the mobile phase. Dilute 5.0 mL of this solution to 100.0 mL with the mobile phase.

Reference solution (b)  Dilute 1.0 mL of reference solution (a) to 10.0 mL with the mobile phase.

Reference solution (c)  Dissolve 5.0 mg of 4-aminophenol R, 5 mg of paracetamol CRS and 5.0 mg of chloroacetanilide R in methanol R and dilute to 20.0 mL with the same solvent. Dilute 1.0 mL to 250.0 mL with the mobile phase.

Reference solution (d)  Dissolve 20.0 mg of 4-nitrophenol R in methanol R and dilute to 50.0 mL with the same solvent. Dilute 1.0 mL to 20.0 mL with the mobile phase.

Column:
  • size: l = 0.25 m, Ø = 4.6 mm,
  • temperature: 35 °C.

Mobile phase  Mix 375 volumes of a 17.9 g/L solution of disodium hydrogen phosphate R, 375 volumes of a 7.8 g/L solution of sodium dihydrogen phosphate R and 250 volumes of methanol R containing 4.6 g/L of a 400 g/L solution of tetrabutylammonium hydroxide R.

Flow rate  1.5 mL/min.

Detection  Spectrophotometer at 245 nm.

Injection  20 µL.

Run time  12 times the retention time of paracetamol.

Relative retentions  With reference to paracetamol (retention time = about 4 min): impurity K = about 0.8; impurity F = about 3; impurity J = about 7.

System suitability  Reference solution (c):

  • resolution: minimum 4.0 between the peaks due to impurity K and to paracetamol,
  • signal-to-noise ratio: minimum 50 for the peak due to impurity J.
Limits:
  • impurity J: not more than 0.2 times the area of the corresponding peak in the chromatogram obtained with reference solution (c) (10 ppm),
  • impurity K: not more than the area of the corresponding peak in the chromatogram obtained with reference solution (c) (50 ppm),
  • impurity F: not more than half the area of the corresponding peak in the chromatogram obtained with reference solution (d) (0.05 per cent),
  • any other impurity: not more than half the area of the principal peak in the chromatogram obtained with reference solution (a) (0.05 per cent),
  • total of other impurities: not more than the area of the principal peak in the chromatogram obtained with reference solution (a) (0.1 per cent),
  • disregard limit for the calculation of the total of other impurities: the area of the principal peak in the chromatogram obtained with reference solution (b) (0.01 per cent).
Heavy metals (2.4.8)

Maximum 20 ppm.

Dissolve 1.0 g in a mixture of 15 volumes of water R and 85 volumes of acetone R and dilute to 20 mL with the same mixture of solvents. 12 mL of the solution complies with limit test B. Prepare the standard using lead standard solution (1 ppm Pb) obtained by diluting lead standard solution (100 ppm Pb) R with a mixture of 15 volumes of water R and 85 volumes of acetone R.

Loss on drying (2.2.32)

Maximum 0.5 per cent, determined on 1.000 g by drying in an oven at 105 °C.

Sulfated ash (2.4.14)

Maximum 0.1 per cent, determined on 1.0 g.

ASSAY

Dissolve 0.300 g in a mixture of 10 mL of water R and 30 mL of dilute sulfuric acid R. Boil under a reflux condenser for 1 h, cool and dilute to 100.0 mL with water R. To 20.0 mL of the solution add 40 mL of water R, 40 g of ice, 15 mL of dilute hydrochloric acid R and 0.1 mL of ferroin R. Titrate with 0.1 M cerium sulfate until a greenish-yellow colour is obtained. Carry out a blank titration.

1 mL of 0.1 M cerium sulfate is equivalent to 7.56 mg of C8H9NO2.

STORAGE

Protected from light.

IMPURITIES

bp2013_v2_13_medicinal_and_pharmaceutical_substances_14 paracetamol_2_2012_70_cs.png


A. R1 = R3 = R4 = H, R2 = OH: N-(2-hydroxyphenyl)acetamide,

B. R1 = CH3, R2 = R3 = H, R4 = OH: N-(4-hydroxyphenyl)propanamide,

C. R1 = R2 = H, R3 = Cl, R4 = OH: N-(3-chloro-4-hydroxyphenyl)acetamide,

D. R1 = R2 = R3 = R4 = H: N-phenylacetamide,

H. R1 = R2 = R3 = H, R4 = O-CO-CH3: 4-(acetylamino)phenyl acetate,

J. R1 = R2 = R3 = H, R4 = Cl: N-(4-chlorophenyl)acetamide (chloroacetanilide),

bp2013_v2_13_medicinal_and_pharmaceutical_substances_14 paracetamol_3_2012_70_cs.png


E. X = O, R2 = H, R4 = OH: 1-(4-hydroxyphenyl)ethanone,

G. X = N-OH, R2 = H, R4 = OH: 1-(4-hydroxyphenyl)ethanone oxime,

I. X = O, R2 = OH, R4 = H: 1-(2-hydroxyphenyl)ethanone,

bp2013_v2_13_medicinal_and_pharmaceutical_substances_14 paracetamol_4_2012_70_cs.png


F. R = NO2: 4-nitrophenol,

K. R = NH2: 4-aminophenol.

Ph Eur